questionsmedicales.fr
Administration des services de santé
Organisation et administration
Gestion du risque
Gestion du risque : Questions médicales fréquentes
Termes MeSH sélectionnés :
Interrupted Time Series Analysis
Diagnostic
5
Gestion des risques
Évaluation des risques
Indicateurs de santé
Infections nosocomiales
Analyse de risque
Gestion des risques
Interactions médicamenteuses
Antécédents médicaux
Retour d'expérience
Sécurité des patients
Symptômes
5
Symptômes
Douleur thoracique
Réaction indésirable
Eruptions cutanées
Erreur médicamenteuse
Nausées
Complications post-opératoires
Saignement
Prévention
5
Hygiène hospitalière
Sécurité des patients
Sensibilisation
Formations
Engagement des patients
Prévention des risques
Infections nosocomiales
Désinfection
Prévention des chutes
Évaluation des risques
Traitements
5
Protocoles de traitement
Formation du personnel
Erreurs de médication
Complications
Chirurgie
Check-lists préopératoires
Communication des risques
Information des patients
Efficacité des traitements
Résultats cliniques
Complications
5
Complications chirurgicales
Infections
Gestion des complications
Ajustement des traitements
Complications graves
État général
Prévention des complications
Soins post-opératoires
Erreurs de médication
Réactions allergiques
Facteurs de risque
5
Facteurs de risque
Infections
Facteurs de risque cardiovasculaires
Hypertension
Comportements à risque
Mauvaise alimentation
Facteurs de risque psychologiques
Anxiété
Facteurs de risque liés à l'âge
Maladies chroniques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Gestion du risque : Questions médicales les plus fréquentes",
"headline": "Gestion du risque : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Gestion du risque : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-14",
"dateModified": "2025-05-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Gestion du risque"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Organisation et administration",
"url": "https://questionsmedicales.fr/mesh/D009934",
"about": {
"@type": "MedicalCondition",
"name": "Organisation et administration",
"code": {
"@type": "MedicalCode",
"code": "D009934",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N04.452"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Participation aux risques financiers",
"alternateName": "Risk Sharing, Financial",
"url": "https://questionsmedicales.fr/mesh/D020414",
"about": {
"@type": "MedicalCondition",
"name": "Participation aux risques financiers",
"code": {
"@type": "MedicalCode",
"code": "D020414",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N04.452.871.800"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Gestion du risque",
"alternateName": "Risk Management",
"code": {
"@type": "MedicalCode",
"code": "D012308",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hal S Wortzel",
"url": "https://questionsmedicales.fr/author/Hal%20S%20Wortzel",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Sean M Barnes",
"url": "https://questionsmedicales.fr/author/Sean%20M%20Barnes",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Bridget B Matarazzo",
"url": "https://questionsmedicales.fr/author/Bridget%20B%20Matarazzo",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Sarra Nazem",
"url": "https://questionsmedicales.fr/author/Sarra%20Nazem",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Universal HIV screening in the emergency department: an interrupted time series analysis.",
"datePublished": "2022-06-22",
"url": "https://questionsmedicales.fr/article/35730396",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/QAD.0000000000003282"
}
},
{
"@type": "ScholarlyArticle",
"name": "Trauma team leader and early mortality: An interrupted time series analysis.",
"datePublished": "2022-10-07",
"url": "https://questionsmedicales.fr/article/36244124",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajem.2022.09.048"
}
},
{
"@type": "ScholarlyArticle",
"name": "Suicide among soldiers and social contagion effects: An interrupted time-series analysis.",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36746079",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.socscimed.2023.115747"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of the economic recession on suicide mortality in Brazil: interrupted time series analysis.",
"datePublished": "2022-06-10",
"url": "https://questionsmedicales.fr/article/35703676",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0034-7167-2021-0778"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health worker protests and the COVID-19 pandemic: an interrupted time-series analysis.",
"datePublished": "2024-07-04",
"url": "https://questionsmedicales.fr/article/39219771",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2471/BLT.23.290330"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Administration des services de santé",
"item": "https://questionsmedicales.fr/mesh/D006298"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organisation et administration",
"item": "https://questionsmedicales.fr/mesh/D009934"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gestion du risque",
"item": "https://questionsmedicales.fr/mesh/D012308"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Gestion du risque - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Gestion du risque",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Gestion du risque",
"description": "Comment évaluer les risques en milieu hospitalier ?\nQuels indicateurs de risque surveiller ?\nQu'est-ce qu'une analyse de risque ?\nComment identifier les risques liés aux traitements ?\nQuel rôle joue le retour d'expérience ?",
"url": "https://questionsmedicales.fr/mesh/D012308?mesh_terms=Interrupted+Time+Series+Analysis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Gestion du risque",
"description": "Quels symptômes signalent un risque accru ?\nComment reconnaître une réaction indésirable ?\nQuels signes d'infection surveiller ?\nQuels symptômes d'une erreur médicamenteuse ?\nComment détecter une complication post-opératoire ?",
"url": "https://questionsmedicales.fr/mesh/D012308?mesh_terms=Interrupted+Time+Series+Analysis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Gestion du risque",
"description": "Quelles mesures préventives en milieu hospitalier ?\nComment sensibiliser le personnel aux risques ?\nQuel rôle des patients dans la prévention des risques ?\nComment prévenir les infections nosocomiales ?\nQuelles sont les stratégies de prévention des chutes ?",
"url": "https://questionsmedicales.fr/mesh/D012308?mesh_terms=Interrupted+Time+Series+Analysis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Gestion du risque",
"description": "Comment minimiser les risques lors des traitements ?\nQuel est l'impact des erreurs de médication ?\nComment gérer les risques liés à la chirurgie ?\nQuelles sont les stratégies de communication des risques ?\nComment évaluer l'efficacité des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D012308?mesh_terms=Interrupted+Time+Series+Analysis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Gestion du risque",
"description": "Quelles complications peuvent survenir après une chirurgie ?\nComment gérer les complications liées aux traitements ?\nQuels sont les signes d'une complication grave ?\nComment prévenir les complications post-opératoires ?\nQuelles sont les complications des erreurs de médication ?",
"url": "https://questionsmedicales.fr/mesh/D012308?mesh_terms=Interrupted+Time+Series+Analysis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Gestion du risque",
"description": "Quels sont les facteurs de risque pour les infections ?\nComment identifier les facteurs de risque cardiovasculaires ?\nQuels comportements augmentent les risques de complications ?\nComment évaluer les facteurs de risque psychologiques ?\nQuels sont les facteurs de risque liés à l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D012308?mesh_terms=Interrupted+Time+Series+Analysis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer les risques en milieu hospitalier ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des outils d'analyse des risques et des audits réguliers."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de risque surveiller ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller les infections nosocomiales, les erreurs médicamenteuses et les chutes."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une analyse de risque ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un processus systématique pour identifier et évaluer les risques potentiels."
}
},
{
"@type": "Question",
"name": "Comment identifier les risques liés aux traitements ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer les antécédents médicaux et les interactions médicamenteuses."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le retour d'expérience ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il permet d'apprendre des incidents passés pour améliorer la sécurité."
}
},
{
"@type": "Question",
"name": "Quels symptômes signalent un risque accru ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes tels que douleur thoracique, essoufflement ou confusion."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction indésirable ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller des signes comme éruptions cutanées ou gonflements après un traitement."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, rougeur, gonflement ou écoulement au site d'intervention."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une erreur médicamenteuse ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Nausées, vertiges ou changements d'état mental après la médication."
}
},
{
"@type": "Question",
"name": "Comment détecter une complication post-opératoire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller des signes comme douleur intense, fièvre ou saignement."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives en milieu hospitalier ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Mettre en place des protocoles d'hygiène et de sécurité des patients."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser le personnel aux risques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Organiser des formations régulières et des simulations de situations à risque."
}
},
{
"@type": "Question",
"name": "Quel rôle des patients dans la prévention des risques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients doivent être informés et impliqués dans leur propre soin."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections nosocomiales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Appliquer des protocoles stricts de désinfection et de stérilisation."
}
},
{
"@type": "Question",
"name": "Quelles sont les stratégies de prévention des chutes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer les risques individuels et adapter l'environnement des patients."
}
},
{
"@type": "Question",
"name": "Comment minimiser les risques lors des traitements ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des protocoles standardisés et former le personnel médical."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des erreurs de médication ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des complications graves et prolonger l'hospitalisation."
}
},
{
"@type": "Question",
"name": "Comment gérer les risques liés à la chirurgie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer les antécédents du patient et suivre des check-lists préopératoires."
}
},
{
"@type": "Question",
"name": "Quelles sont les stratégies de communication des risques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer les patients des risques et bénéfices des traitements proposés."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des indicateurs de résultats cliniques et des retours des patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une chirurgie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections, saignements, thromboses ou complications respiratoires."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées aux traitements ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller les patients et ajuster les traitements en fonction des symptômes."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une complication grave ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleur intense, fièvre élevée ou détérioration rapide de l'état général."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications post-opératoires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre des protocoles de soins post-opératoires et surveiller les patients."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications des erreurs de médication ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Réactions allergiques, surdosage ou échec thérapeutique."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les infections ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Âge avancé, immunodépression et interventions chirurgicales récentes."
}
},
{
"@type": "Question",
"name": "Comment identifier les facteurs de risque cardiovasculaires ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer l'hypertension, le diabète, le tabagisme et l'hypercholestérolémie."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent les risques de complications ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Tabagisme, sédentarité et mauvaise alimentation sont des comportements à risque."
}
},
{
"@type": "Question",
"name": "Comment évaluer les facteurs de risque psychologiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Considérer l'anxiété, la dépression et le stress dans l'évaluation globale."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque liés à l'âge ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé augmente le risque de maladies chroniques et de complications."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/05/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Publications dans "Gestion du risque" :
4 publications dans cette catégorie
Publications dans "Gestion du risque" :
4 publications dans cette catégorie
Publications dans "Gestion du risque" :
4 publications dans cette catégorie
Publications dans "Gestion du risque" :
3 publications dans cette catégorie
Publications dans "Gestion du risque" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, World University of Bangladesh, Bangladesh.
Publications dans "Gestion du risque" :
2 publications dans cette catégorie
Publications dans "Gestion du risque" :
2 publications dans cette catégorie
Publications dans "Gestion du risque" :
2 publications dans cette catégorie
Publications dans "Gestion du risque" :
2 publications dans cette catégorie
Publications dans "Gestion du risque" :
2 publications dans cette catégorie
Publications dans "Gestion du risque" :
2 publications dans cette catégorie
Publications dans "Gestion du risque" :
2 publications dans cette catégorie
Publications dans "Gestion du risque" :
2 publications dans cette catégorie
Affiliations :
Ms. Vanderpool is Director of Risk Management at Professional Risk Management Services (PRMS).
Publications dans "Gestion du risque" :
1 publication dans cette catégorie
Affiliations :
Risk Management Department, Maccabi HMO.
Publications dans "Gestion du risque" :
1 publication dans cette catégorie
Affiliations :
Risk Management Department, Maccabi HMO.
Publications dans "Gestion du risque" :
1 publication dans cette catégorie
Affiliations :
Risk Management Department, Maccabi HMO.
Publications dans "Gestion du risque" :
1 publication dans cette catégorie
Affiliations :
Risk Management Department, Maccabi HMO.
Publications dans "Gestion du risque" :
1 publication dans cette catégorie
Affiliations :
MedStar Georgetown University Hospital.
Publications dans "Gestion du risque" :
1 publication dans cette catégorie
Publications dans "Gestion du risque" :
We performed a calendar-matched, 12-month, before (November 27, 2017 to November 26, 2018) and after (November 27, 2018 to November 26, 2019) study, to assess the utility of an emergency department-ba...
The trauma team leader (TTL) is a "model" of a specifically dedicated team leader in the emergency department (ED), but its benefits are uncertain. The primary objective was to assess the impact of th...
Major trauma admissions (Injury Severity Score (ISS)≥12) in 3 Canadian Level-1 trauma centres were included from 2003 to 2017. The TTL program was implemented in centre 1 in 2005. An interrupted time ...
TTL implementation was not associated with changes in mortality or admission delays from the ED. Future studies should assess the potential impact of TTL programs on other patient-centred outcomes usi...
Suicide has become an increasingly concerning problem among soldiers in recent years. Previous research has hypothesized that media-related social contagion effects, termed "Werther effects," may cont...
An interrupted time-series analysis, relying on annual military suicide rates between 1873 and 1910, indicated a significant increase in the suicide rate the year of Rudolf's death, a pattern consiste...
Although we are very careful when interpreting causal effects with our historical data, we discuss the latter finding by questioning whether a change in military culture, that is, the establishment of...
to analyze trends in suicide rates in Brazil in the period before and after the start of the economic recession....
interrupted time series research using national suicide data recorded in the period between 2012 and 2017 with socioeconomic subgroups analyses. Quasi-Poisson regression model was employed to analyze ...
there was an abrupt increase in the risk of suicide after economic recession in the population with less education (12.5%; RR = 1.125; 95%CI: 1.027; 1.232) and in the South Region (17.7%; 1.044; 1.328...
the Brazilian economic recession caused different effects on suicide rates, considering social strata, which requires health strategies and policies that are sensitive to the most vulnerable populatio...
To assess the impact of the coronavirus disease 2019 (COVID-19) pandemic on protests by health workers....
We conducted an interrupted time series analysis of data from 159 countries for 2 years before and after the World Health Organization classified COVID-19 as a pandemic in March 2020, thus between 201...
In total, there were 18 322 health worker protests in 133 countries between 2018 and 2022. The number of weekly health worker protests globally increased by 47% (30.1/63.5), an increase of 30.1 protes...
The pandemic increased the overall level of health worker protests globally as well as the number of countries experiencing such protests. These protests highlight discontent in the health workforce. ...
We are sometimes forced to use the Interrupted Time Series (ITS) design as an identification strategy for potential policy change, such as when we only have a single treated unit and cannot obtain com...
We hypothesized that children with Down syndrome who were born after the implementation of first-trimester combined screening for trisomy 13, 18, and 21 and a second-trimester ultrasound scan in Denma...
A nationwide register-based study of all live born singletons with Down syndrome in Denmark from 1995 to 2018. In interrupted time series analyses, we studied the temporal developments in birth biomet...
We included 602 singletons with Down syndrome born before and 308 after implementation of the screening program. Z-scores of birthweight and head circumference increased over time before screening, bu...
After implementation of a national prenatal screening program, we did not observe a milder Down syndrome phenotype apart from an apparent reduction in the proportion of children with non-severe congen...
In Australia, the available published literature demonstrated a spike in dispensed prescription medicines after the onset of the COVID-19 pandemic that subsequently returned to expected levels. Smokin...
Australia's universal health-care system provides access to government-subsidised medicines via the Pharmaceutical Benefits Scheme and records of dispensed medicines are publicly available on a nation...
After an initial spike in medicines at the onset of the pandemic, the monthly rate of prescriptions dispensed for varenicline was predominantly within predicted ranges, while that of NRT patches was p...
There has been a differential change in the number of subsidised smoking cessation medicines supplied in Australia since the COVID-19 pandemic, with varenicline prescriptions largely within, and NRT p...
To evaluate the seasonality of acute bronchiolitis in Brazil during the 2020-2022 season and compare it with the previous seasons....
Data from the incidence of hospitalizations due to acute bronchiolitis in infants <1 year of age were obtained from the Department of Informatics of the Brazilian Public Health database for the period...
Compared to the pre-COVID-19 period, the incidence of hospitalizations related to acute bronchiolitis decreased by 97% during non-pharmacological interventions (March 2020 - August 2021) but increased...
This study underscores the significant influence of COVID-19 interventions on acute bronchiolitis hospitalizations in Brazil. The restoration of a seasonal pattern in 2022 highlights the interplay bet...
The aim of this study is to reveal the impact of the COVID-19 pandemic, which constitutes an extraordinary situation, on the habits of emergency health service use. The data of the study consist of em...